Loading...
Monitor tumor burden with circulating tumor DNA
There is a need to identify better biomarkers to monitor diseases and/or assess therapeutic responses. For those with cancer, one can identify DNA fragments that contain somatic mutations originating in the tumor DNA in plasma or serum. There have been several early studies suggesting that advances...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3841207/ https://ncbi.nlm.nih.gov/pubmed/23792566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.25361 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|